Stroma-epithelium crosstalk in prostate cancer.

The critical role played by stroma-epithelium crosstalk in carcinogenesis and progression of prostate cancer has been increasingly recognized. These interactions are mediated by a variety of paracrine factors secreted by cancer cells and/or stromal cells. In human prostate cancer, reactive stroma is characterized by an increase in myofibroblasts and a corresponding amplification of extracellular matrix production and angiogenesis. Permanent genetic mutations have been reported in stromal cells as well as in tumour cells. Transforming growth factor-beta, vascular endothelial growth factor, platelet-derived growth factor and fibroblast growth factor signalling pathways are involved in the process of angiogenesis, whereas hepatocyte growth factor, insulin-like growth factor-1, epidermal growth factor, CXC12 and Interleukin-6 play active roles in the progression, androgen-independent conversion and distal metastasis of prostate cancer. Some soluble factors have reciprocal interactions with androgens and the androgen receptor (AR), and can even activate AR in the absence of the androgen ligand. In this article, we review the complex interactions between cancer cells and the surrounding microenvironment, and discuss the potential therapeutic targets in the stromal compartment of prostate cancer.

[1]  M. Ittmann,et al.  The role of fibroblast growth factors and their receptors in prostate cancer. , 2004, Endocrine-related cancer.

[2]  D. Tindall,et al.  TGF-betal/Smad signaling in prostate cancer. , 2003, Current drug targets.

[3]  H. Jin,et al.  Integrins: roles in cancer development and as treatment targets , 2004, British Journal of Cancer.

[4]  M. Gerdes,et al.  Regulation of rat prostate stromal cell myodifferentiation by androgen and TGF‐β1 , 2004, The Prostate.

[5]  P. Nelson,et al.  Interaction of IGF signaling and the androgen receptor in prostate cancer progression , 2006, Journal of cellular biochemistry.

[6]  Hui Wang,et al.  Androgenic control of transforming growth factor-beta signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-beta receptor II. , 2008, Cancer research.

[7]  P. Scherle,et al.  Targeting the c-MET signaling pathway for cancer therapy , 2008 .

[8]  R. Sutherland,et al.  Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. , 2001, Cancer research.

[9]  L. Eaves,et al.  cDNA microarray analysis identifies genes induced in common by peptide growth factors and androgen in human prostate epithelial cells , 2005, Molecular carcinogenesis.

[10]  D. Horsfall,et al.  Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non‐organ confined disease , 2005, The Prostate.

[11]  Anna Johansson,et al.  A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model , 2007, The Prostate.

[12]  R. Vessella,et al.  The role of tumor microenvironment in prostate cancer bone metastasis , 2007, Journal of cellular biochemistry.

[13]  R. Roberts,et al.  The loss of TGF-beta signaling promotes prostate cancer metastasis. , 2003, Neoplasia.

[14]  L. Chung,et al.  Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. , 2005, The Journal of urology.

[15]  K. Jennbacken,et al.  Expression of vascular endothelial growth factor C (VEGF‐C) and VEGF receptor‐3 in human prostate cancer is associated with regional lymph node metastasis , 2005, The Prostate.

[16]  Yuzhuo Wang,et al.  The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression. , 2007, Cancer research.

[17]  R. West,et al.  Experimental approaches to the study of cancer–stroma interactions: recent findings suggest a pivotal role for stroma in carcinogenesis , 2007, Laboratory Investigation.

[18]  D. Tindall,et al.  TGF-ß/Smad Signaling in Prostate Cancer , 2003 .

[19]  P. Limonta,et al.  Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I. , 2007, International journal of oncology.

[20]  T. Kole,et al.  Fibroblast activation protein peptide substrates identified from human collagen I derived gelatin cleavage sites. , 2008, Biochemistry.

[21]  R. Dhir,et al.  Microenvironment of Prostate Cancer Receptor-Coregulator Recruitment Is Altered in the Tissue Stromal-Epithelial Cell Interactions and Androgen , 2007 .

[22]  K. Williams,et al.  Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. , 2006, Cancer research.

[23]  H. Moses,et al.  Stromal fibroblasts in cancer initiation and progression , 2004, Nature.

[24]  S. Batra,et al.  Prostate‐derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor‐positive human prostate cancer cells , 2007, The Prostate.

[25]  G. Ayala,et al.  Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[27]  D. Danielpour.  Functions and regulation of transforming growth factor-beta (TGF-beta) in the prostate. , 2005, European journal of cancer.

[28]  J. S. Rao,et al.  CpG island promoter methylation and silencing of 14-3-3σ gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2 , 2006, Oncogene.

[29]  W. Mckeehan,et al.  Exon switching and activation of stromal and embryonic fibroblast growth factor (FGF)-FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy , 1993, Molecular and cellular biology.

[30]  P. Hein,et al.  Carcinoma-associated fibroblasts stimulate tumor progression of initiated human epithelium , 2000, Breast Cancer Research.

[31]  M. T. Story,et al.  Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells , 1996, The Prostate.

[32]  J. Gillespie,et al.  Gene promoter methylation in prostate tumor-associated stromal cells. , 2006, Journal of the National Cancer Institute.

[33]  Jianhua Wang,et al.  Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. , 2005, Cellular signalling.

[34]  M. S. Condon.  The role of the stromal microenvironment in prostate cancer. , 2005, Seminars in cancer biology.

[35]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[36]  S. Hayward,et al.  Malignant transformation in a nontumorigenic human prostatic epithelial cell line. , 2001, Cancer research.

[37]  Yi Lu,et al.  Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. , 2006, Cancer research.

[38]  Brian Bierie,et al.  Under Pressure: Stromal Fibroblasts Change Their Ways , 2005, Cell.

[39]  Yulan Jin,et al.  Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate. , 2003, Oncology reports.

[40]  A. Gudkov,et al.  Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells , 2004 .

[41]  P. Greenberg,et al.  Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. , 1998, Endocrinology.

[42]  Zhiwei Wang,et al.  Platelet‐Derived Growth Factor‐D Overexpression Contributes to Epithelial‐Mesenchymal Transition of PC3 Prostate Cancer Cells , 2008, Stem cells.

[43]  Georg Bartsch,et al.  Interleukin‐6 regulation of prostate cancer cell growth , 2005, Journal of cellular biochemistry.

[44]  A. Angelucci,et al.  Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity , 2005, Thrombosis and Haemostasis.

[45]  Liang Cheng,et al.  Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model. , 2004, Anticancer research.

[46]  A. Multani,et al.  Can cancer cells transform normal host cells into malignant cells? , 1997, British Journal of Cancer.

[47]  K. Pienta,et al.  Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells , 2005 .

[48]  P. Febbo,et al.  Stromally expressed c-Jun regulates proliferation of prostate epithelial cells. , 2007, The American journal of pathology.

[49]  L. Ye,et al.  HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells. , 2008, Urologic oncology.

[50]  L. Chung,et al.  Co‐inoculation of tumorigenic rat prostate mesenchymal cells with non‐tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals , 1989, International journal of cancer.

[51]  J. Gillespie,et al.  Identification of a unique epigenetic sub‐microenvironment in prostate cancer , 2007, The Journal of pathology.

[52]  N. Maitland,et al.  Androgen receptor signalling in prostate: Effects of stromal factors on normal and cancer stem cells , 2008, Molecular and Cellular Endocrinology.

[53]  E. Baldi,et al.  EGF receptor (EGFR) signaling promoting invasion is disrupted in androgen‐sensitive prostate cancer cells by an interaction between EGFR and androgen receptor (AR) , 2004, International journal of cancer.

[54]  R. Cowan,et al.  Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome. , 2007, International journal of radiation oncology, biology, physics.

[55]  P. Stattin,et al.  Castration‐induced epithelial cell death in human prostate tissue is related to locally reduced IGF‐1 levels , 2007, The Prostate.

[56]  P. Stattin,et al.  Nuclear androgen receptors recur in the epithelial and stromal compartments of malignant and non‐malignant human prostate tissue several months after castration therapy , 2007, The Prostate.

[57]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[58]  N. Maitland,et al.  Precise microdissection of human prostate cancers reveals genotypic heterogeneity. , 1998, Cancer research.

[59]  Donald E Ingber,et al.  Cancer as a disease of epithelial-mesenchymal interactions and extracellular matrix regulation. , 2002, Differentiation; research in biological diversity.

[60]  L. Chung,et al.  Hypoxia increases VEGF-A production by prostate cancer and bone marrow stromal cells and initiates paracrine activation of bone marrow endothelial cells , 2006, Clinical & Experimental Metastasis.

[61]  Abraham Schneider,et al.  Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[62]  J. Arnold,et al.  Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[63]  Kirsten L. Greene,et al.  CpG methylation at promoter site −140 inactivates TGFβ2 receptor gene in prostate cancer , 2005, Cancer.

[64]  C. Heldin,et al.  New members of the platelet-derived growth factor family of mitogens. , 2002, Archives of biochemistry and biophysics.

[65]  J. Schalken,et al.  Complex cadherin expression in human prostate cancer cells , 2000, International journal of cancer.

[66]  Kathleen A. Hinchman,et al.  Progression , 1896, Journal of Adolescent & Adult Literacy.

[67]  Feng Yang,et al.  Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. , 2005, Cancer research.

[68]  Kornelia Polyak,et al.  Microenvironmental regulation of cancer development. , 2008, Current opinion in genetics & development.

[69]  前田 明信.  Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells , 2007 .

[70]  S. Persad,et al.  Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells , 2008, Cancer Cell International.

[71]  G. Ghersi.  Roles of molecules involved in epithelial/mesenchymal transition during angiogenesis. , 2008, Frontiers in bioscience : a journal and virtual library.

[72]  C. Pettaway,et al.  Blockade of Transforming Growth Factor-β Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude Mice , 2005, Clinical Cancer Research.

[73]  K. Williams,et al.  Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. , 2007, Cancer research.

[74]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[75]  J. Grootegoed,et al.  Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling. , 2005, Endocrine-related cancer.

[76]  B. Knudsen,et al.  Prostate cancer and the met hepatocyte growth factor receptor. , 2004, Advances in cancer research.

[77]  J. Schalken,et al.  Cadherin switching in human prostate cancer progression. , 2000, Cancer research.

[78]  A. Gao,et al.  Interleukin‐6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression , 2007, The Prostate.

[79]  H. Moses,et al.  Tumor-stroma interactions. , 2005, Current opinion in genetics & development.

[80]  L. Chung,et al.  Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells , 2006, BMC Cancer.

[81]  Robert D. Cardiff,et al.  Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis , 2005, Cell.

[82]  T. Ratliff.  TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .

[83]  Olivier De Wever,et al.  Role of tissue stroma in cancer cell invasion , 2003, The Journal of pathology.